Sponsor or institution

Clinical trials and research at BeBetter Med Inc

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• BEBT-209 plus chemotherapy in advanced/metastatic triple-negative breast cancer

  A new drug, BEBT-209, is being tested with standard chemotherapy to see if it helps people with locally advanced or metastatic triple-negative breast cancer.

  Recruiting at 2 sites Phase 2/3 BeBetter Med Inc · Guangzhou, Guangdong and 1 other locations · NCT07544056

• BEBT-701 in adults with high blood pressure and high LDL-C

  A first-in-early study to test BEBT-701, given by injection, for safety, how it behaves in the body, and any signs it helps with blood pressure and LDL cholesterol in adults with mild–moderate hypertension.

  Recruiting Phase 1/2 BeBetter Med Inc · Changsha, Hunan · NCT07368608

• BEBT-507 Injection for Polycythemia Vera

  This study tests BEBT-507 to see if it is safe and possibly helpful for adults with polycythemia vera who have not responded well to standard therapies.

  Recruiting Phase 1 BeBetter Med Inc · Tianjin, Tianjin Municipality · NCT07012109

• BEBT-209 with fulvestrant for HR+/HER2- advanced or metastatic breast cancer after prior hormone therapy

  This trial will test whether adding the experimental oral drug BEBT-209 to fulvestrant helps women with HR+/HER2- advanced or metastatic breast cancer that progressed after prior endocrine therapy.

  Recruiting Phase 3 BeBetter Med Inc · Beijing, Beijing Municipality · NCT06998108

• Comparing BEBT-908 with Rituximab to Standard Chemotherapy for Lymphoma

  This study is testing whether a new treatment called BEBT-908 combined with rituximab can work better than standard chemotherapy for people with relapsed or hard-to-treat diffuse large B-cell lymphoma.

  Recruiting Phase 3 BeBetter Med Inc · Beijing, Beijing Municipality · NCT06792253

• BEBT-109 treatment for lung cancer with specific mutations

  This study is testing a new drug called BEBT-109 to see if it can help people with a specific type of lung cancer that has certain mutations, especially those who haven't had much success with other treatments.

  Recruiting at 2 sites Phase 2 BeBetter Med Inc · Guangzhou, Guangdong and 1 other locations · NCT06706713

• BEBT-109 with standard chemotherapy as first-line treatment for NSCLC with EGFR Exon 20 Insertion

  This trial tests BEBT-109 (alone or with pemetrexed plus platinum) to treat adults with non-small cell lung cancer that has EGFR Exon 20 insertion mutations and is locally advanced, recurrent, or metastatic.

  Recruiting Phase 2 BeBetter Med Inc · Guangzhou, Guangdong · NCT06514027

Quick answers

How many clinical trials run by BeBetter Med Inc are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 2, Phase 2/3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →